Literature DB >> 17908927

A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease.

Alan Cheng1, Mei Zhang, Matthew S Gentry, Carolyn A Worby, Jack E Dixon, Alan R Saltiel.   

Abstract

Cori's disease is a glycogen storage disorder characterized by a deficiency in the glycogen debranching enzyme, amylo-1,6-glucosidase,4-alpha-glucanotransferase (AGL). Here, we demonstrate that the G1448R genetic variant of AGL is unable to bind to glycogen and displays decreased stability that is rescued by proteasomal inhibition. AGL G1448R is more highly ubiquitinated than its wild-type counterpart and forms aggresomes upon proteasome impairment. Furthermore, the E3 ubiquitin ligase Malin interacts with and promotes the ubiquitination of AGL. Malin is known to be mutated in Lafora disease, an autosomal recessive disorder clinically characterized by the accumulation of polyglucosan bodies resembling poorly branched glycogen. Transfection studies in HepG2 cells demonstrate that AGL is cytoplasmic whereas Malin is predominately nuclear. However, after depletion of glycogen stores for 4 h, approximately 90% of transfected cells exhibit partial nuclear staining for AGL. Furthermore, stimulation of cells with agents that elevate cAMP increases Malin levels and Malin/AGL complex formation. Refeeding mice for 2 h after an overnight fast causes a reduction in hepatic AGL levels by 48%. Taken together, these results indicate that binding to glycogen crucially regulates the stability of AGL and, further, that its ubiquitination may play an important role in the pathophysiology of both Lafora and Cori's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17908927      PMCID: PMC1993871          DOI: 10.1101/gad.1553207

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  36 in total

Review 1.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

Review 2.  The role of protein phosphatase-1 in insulin action.

Authors:  M J Brady; A R Saltiel
Journal:  Recent Prog Horm Res       Date:  2001

3.  Alternative splicing modulates subcellular localization of laforin.

Authors:  Subramaniam Ganesh; Toshimitsu Suzuki; Kazuhiro Yamakawa
Journal:  Biochem Biophys Res Commun       Date:  2002-03-15       Impact factor: 3.575

4.  Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient.

Authors:  M Okubo; F Kanda; A Horinishi; K Takahashi; S Okuda; K Chihara; T Murase
Journal:  Hum Mutat       Date:  1999-12       Impact factor: 4.878

5.  A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen.

Authors:  Jianyong Wang; Jeanne A Stuckey; Matthew J Wishart; Jack E Dixon
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

6.  Surprises of genetic engineering: a possible model of polyglucosan body disease.

Authors:  N Raben; M Danon; N Lu; E Lee; L Shliselfeld; A V Skurat; P J Roach; J C Lawrence ; O Musumeci; S Shanske; S DiMauro; P Plotz
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

Review 7.  Molecular characterization of glycogen storage disease type III.

Authors:  J J Shen; Y T Chen
Journal:  Curr Mol Med       Date:  2002-03       Impact factor: 2.222

Review 8.  Glycogen and its metabolism.

Authors:  Peter J Roach
Journal:  Curr Mol Med       Date:  2002-03       Impact factor: 2.222

9.  Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL.

Authors:  Y Suzuki; C Lanner; J H Kim; P G Vilardo; H Zhang; J Yang; L D Cooper; M Steele; A Kennedy; C B Bock; A Scrimgeour; J C Lawrence; A A DePaoli-Roach
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

10.  The phosphatase laforin crosses evolutionary boundaries and links carbohydrate metabolism to neuronal disease.

Authors:  Matthew S Gentry; Robert H Dowen; Carolyn A Worby; Seema Mattoo; Joseph R Ecker; Jack E Dixon
Journal:  J Cell Biol       Date:  2007-07-23       Impact factor: 10.539

View more
  50 in total

1.  Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.

Authors:  Anna A DePaoli-Roach; Vincent S Tagliabracci; Dyann M Segvich; Catalina M Meyer; Jose M Irimia; Peter J Roach
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters.

Authors:  Pankaj Kumar Singh; Sweta Singh; Subramaniam Ganesh
Journal:  Mol Cell Biol       Date:  2011-11-28       Impact factor: 4.272

Review 3.  Glycogen phosphorylation and Lafora disease.

Authors:  Peter J Roach
Journal:  Mol Aspects Med       Date:  2015-08-13

4.  Processivity and subcellular localization of glycogen synthase depend on a non-catalytic high affinity glycogen-binding site.

Authors:  Adelaida Díaz; Carlos Martínez-Pons; Ignacio Fita; Juan C Ferrer; Joan J Guinovart
Journal:  J Biol Chem       Date:  2011-04-04       Impact factor: 5.157

Review 5.  [Lafora disease: a review of the literature].

Authors:  L Desdentado; R Espert; P Sanz; J Tirapu-Ustarroz
Journal:  Rev Neurol       Date:  2019-01-16       Impact factor: 0.870

6.  Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.

Authors:  Elisabet Augé; Carme Pelegrí; Gemma Manich; Itsaso Cabezón; Joan J Guinovart; Jordi Duran; Jordi Vilaplana
Journal:  Glia       Date:  2018-08-26       Impact factor: 7.452

7.  AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex.

Authors:  Santiago Vernia; M Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Teresa Rubio; Luisa García-Haro; Marc Foretz; Santiago Rodríguez de Córdoba; Pascual Sanz
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

8.  Distinct mutations in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions.

Authors:  Alan Cheng; Mei Zhang; Minoru Okubo; Kaoru Omichi; Alan R Saltiel
Journal:  Hum Mol Genet       Date:  2009-03-19       Impact factor: 6.150

9.  Abnormal metabolism of glycogen phosphate as a cause for Lafora disease.

Authors:  Vincent S Tagliabracci; Jean Marie Girard; Dyann Segvich; Catalina Meyer; Julie Turnbull; Xiaochu Zhao; Berge A Minassian; Anna A Depaoli-Roach; Peter J Roach
Journal:  J Biol Chem       Date:  2008-10-13       Impact factor: 5.157

10.  Laforin, the most common protein mutated in Lafora disease, regulates autophagy.

Authors:  Carmen Aguado; Sovan Sarkar; Viktor I Korolchuk; Olga Criado; Santiago Vernia; Patricia Boya; Pascual Sanz; Santiago Rodríguez de Córdoba; Erwin Knecht; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-05-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.